Results 151 to 160 of about 10,507 (195)

Lymphocytic Variant Hypereosinophilic Syndrome: Case Series From a Tertiary Referral Center in Canada. [PDF]

EJHaem
Wang XQ, Shopsowitz K, Lofroth J, Wang X, Peterson E, Weng AP, Chen LYC.   +6 more
europepmc   +1 more source

[Hypereosinophilic syndrome].

Boletin medico del Hospital Infantil de Mexico, 1985
R, Herrera-Goepfert, O, Larraza-Hernández   +1 more
openaire   +1 more source

Development and implementation of Phleos, a web-based tool for the data collection on Hypereosinophilic syndrome: the Italian Network on HES (INHES) study protocol. [PDF]

Front Immunol
Nicola S, Caminati M, Borrelli R, Lo Sardo L, Corradi F, Badiu I, Vacca A, Carlucci P, De Paulis A, Mormile I, Zurlo M, Di Gioacchino M, Patella V, Del Giacco S, Costanzo G, Negrini S, Rolla G, Brussino L.   +17 more
europepmc   +1 more source

Refractory Idiopathic Hypereosinophilic Syndrome Presenting with Myocarditis and Responding to Imatinib: A Case Report. [PDF]

Saudi J Med Med Sci
Albayyat RA, AlQahtani SY, Sharofna KA.
europepmc   +1 more source

Idiopathic hypereosinophilic syndrome complicated by computed tomography-negative cerebral infarction, strangulated intestinal obstruction, and hepatic portal venous gas: a case report of multi-system involvement. [PDF]

Quant Imaging Med Surg
Wei H, Ji C, Dong F, Shan Y, Kong W.
europepmc   +1 more source

A Challenging Case of Idiopathic Hypereosinophilic Syndrome: An Itching in the Brain. [PDF]

Cureus
Dube A, Kumbhalkar S, Verma I, Maiti P, Nagpure KB, Ghodeshwar GK.   +5 more
europepmc   +1 more source

An acquired translocation in JAK2 Val617Phe-negative essential thrombocythemia associated with autosomal spread of X-inactivation [PDF]

, 2006
Baxter, E. Joanna, Campbell, Peter J., Culligan, Dominic A., Fourouclas, Nasios, Green, Anthony R., Huntly, Brian J. P., Li, Juan, Munro, Laura R., Roberts, Ian, Scott, Linda M., Swanton, Soheila, Vassiliou, George S.   +11 more
core  

Single-center off-label benralizumab use for refractory hypereosinophilic syndrome demonstrates satisfactory safety and efficacy. [PDF]

EJHaem
Veltman Y, Aalbers AM, Hermans MAW, Mutsaers PGNJ.   +3 more
europepmc   +1 more source

Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome. [PDF]

Br J Haematol
Kim DH, Kim S, Park S, Byun JM, Hong J, Shin DY, Kim I, Bang SM, Lee JO, Lee JY, Kim SA, Kim KH, Chung YJ, Jung SH, Koh Y, Yoon SS.   +15 more
europepmc   +1 more source

The Cleveland Clinic experience of eosinophilic myocarditis in the setting of hypereosinophilic syndrome: demographics, cardiac imaging, and outcomes. [PDF]

Cardiovasc Diagn Ther
Reeder M, Okushi Y, Lo Presti Vega S, Prasad R, Grimm RA, Griffin BP, Xu B.   +6 more
europepmc   +1 more source